Generic Drug Substances

Neuland’s operational expertise has been as a service provider in the manufacturing of Generic Drug Substances. Neuland is recognized as a preferred & reliable API Supplier due to consistency in quality, ability to deal with niche chemistry and on-time delivery.

  • Over 100 APIs across 10 diverse therapeutic areas
  • 916+ Drug Master Files (DMFs) filed worldwide, 62 active US DMFs
  • Support for New Drug Applications (NDAs)
  • Commercial scale cGMP manufacturing
  • Strong regulatory track record with regulatory agencies around the world (FDA, EDQM, BfArM, EMA, PMDA, TGA, ANVISA and others)
  • 3 USFDA & EU GMP compliant facilities with a collective capacity
    of 907 + KL

Neuland is a dedicated 100% API provider
that guarantees not to compete within finished products

Manufacturing Capabilities

3 USFDA Approved cGMP Manufacturing facilities with a total reactor volume of 907,000 liters.

Quality as a focus

Successfully inspected by USFDA (15 times, 2 PAIs), EMA, PMDA, Rx-360, TGA, KFDA, ANVISA, WHO.

Filing Support

Supported 3 NDA filings and 8 IND filings by supplying APIs and CMC documentation.

Tech Transfer

Agile tech transfer at all stages of drug lifecycle or for scale-up.

Regulatory Filings

Filed 916+ DMFs worldwide, with 62 DMFs with USFDA.

Global Clients

Export to more than 80 countries, with 80+ active clients.

Manufacturing Facilities Overview

UNIT-1

Bonthapally,
Hyderabad 234 KL

UNIT-2

Pashamylaram,
Hyderabad 370 KL

UNIT-3

Gaddapotharam,
Hyderabad 303 KL

Year of Establishment 1986 1994 2017
Blocks Block - 1, 2, 3, 4, H, KL & S 34 Block-1, 2, 3, FC, NMSM, Mini plant6 Block - 1, 2, 4, 5
Hydrogenation Reaction Volume 7.4KL 6KL Facility creation under process
Solvent Recovery System 100KL/D 20KL/D 50KL/D
Cryogenic Reaction Volume 25KL 15KL 15KL
Regulatory USFDA, EDQM, CFDA, PMDA, et. al USFDA, EDQM, PMDA, ANVISA et. al Desktop Inspection by USFDA in 2020; ANVISA (Brazil) 2022

Regulatory Support

Neuland has a stellar history of successful regulatory inspections by leading regulatory authorities worldwide.

All our manufacturing sites and the R&D center are routinely inspected by global regulatory authorities to ensure our facilities, processes and products meet the strict cGMP standards.

R&D Capabilities Built

FBRM

Particle size check for polymorph achievement

Peptide lab

9800 sq. ft. new lab with additional 7 hoods for 25 chemists

Poly Block Reactors

For solubility/ crystallisation study, carrying out multiple reactions

Laboratory Reactors

Enhanced ability to perform reactions in a wide range of -90 to 200℃

R&D capabilities built

Hazardous & Wet Laboratory

Dedicated area for hazardous chemical management and wet lab expansion

ID Laboratory, Unit-III

To address product quality issues, impurities synthesis, cost reduction

PID Laboratory, B-S, Unit-I

Expansion with 3 fume hoods along with space for 2 more laboratories.

Heating & Cooling Systems

For DoE studies and projects

About Neuland Laboratories

Established in 1984, Neuland Laboratories is an end-to-end solutions provider for the pharmaceutical industry’s chemistry needs as a leading manufacturer of active pharmaceutical ingredients (APIs). Supported by three world-class US FDA and EU GMP compliant manufacturing facilities and complex chemistry capabilities, Neuland has become a trusted partner for innovators as well as generics.

Our Custom Manufacturing Solutions span the full range of the pharmaceutical industry’s chemistry requirements, from pre-IND through commercial manufacturing.

We offer both small-scale clinical trial quantities and full commercial-scale supply with minimal tech transfer timelines. Our R&D facility is approved by the Department of Scientific and Industrial Research and inspected by the USFDA without any observations. The facility houses development labs, analytical labs, a kilo lab for scale-up and dedicated lab for peptides.

The company is headquartered in Hyderabad, India and the manufacturing and research facilities are situated near Hyderabad. Neuland is reliable manufacturing and development partner to customers in over 80 countries across US, Europe, Japan, APAC, India, MENA and LATAM.